Weight loss drug giants have made new moves! $1.3 billion acquisition of hypertension drug Oceanone
chilunl
发表于 2023-10-17 10:11:12
3638
0
0
On Monday, local time, Novo Nordisk, the manufacturer of the "slimming miracle drug", announced that it has agreed to purchase a hypertension control drug, Octurenone, from KBP Biosciences for up to $1.3 billion. This is a continuation of Novo Nordisk's recent series of transactions to strengthen its drug product line.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- The sharp decline in the Japanese stock market caused Buffett to lose 550 billion yen! Industry hot topic: Will stock gods still increase their positions?
- Will the "summer storm" of the global market, led by the US CPI, continue this week?
- I just directed 'Black Monday' last month! Will there be another thunderstorm tonight during non farm hours?
- NIO adjusts the charging model for battery swapping service fees: charged per kilowatt hour, and Ledao will continue to use it for battery swapping in the future
- A lone star! How long can the myth of the Indian stock market, which has risen above the P&500 index within the year, continue?
- Huang Renxun, Su Zifeng, Nadella, and Xiaozha are all here. What did the AI giants discuss together?
- After 13 years, JD has accessed Alipay again. Insiders said that reverse cooperation is also advancing
- Comments from various sectors in the United States on non farm farming: Can 12000 yuan still be used for "American style downgrading"? The expectation of interest rate cuts has stabilized
- Comments from various sectors in the United States on non farm farming: Can 12000 yuan still be used for "American style downgrading"? The expectation of interest rate cuts has stabilized
- Gold must also be willing to bow down to the enemy! The price of military metal antimony has doubled this year